{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:24:20Z","timestamp":1783549460266,"version":"3.55.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"28","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Helsinki University Hospital"},{"name":"VTR-funding","award":["TYH2021126"],"award-info":[{"award-number":["TYH2021126"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,21]]},"DOI":"10.1093\/eurheartj\/ehab276","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T20:21:03Z","timestamp":1619554863000},"page":"2761-2764","source":"Crossref","is-referenced-by-count":18,"title":["Coronary artery disease: \u2018gout\u2019 in the artery?"],"prefix":"10.1093","volume":"42","author":[{"given":"Timo E","family":"Strandberg","sequence":"first","affiliation":[{"name":"University of Helsinki, Clinicum, and Helsinki University Hospital , Haartmaninkatu 4, PO Box 340, FIN-00029 Helsinki, Finland"},{"name":"University of Oulu, Center for Life Course Health Research , Aapistie 5, 90014 Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-367X","authenticated-orcid":false,"given":"Petri T","family":"Kovanen","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute , Haartmaninkatu 8, 00290 Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"2022102708475990500_ehab276-B1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102708475990500_ehab276-B2","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102708475990500_ehab276-B3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102708475990500_ehab276-B4","article-title":"Uric acid and cardiovascular disease: a clinical review","author":"Saito","year":"2020","journal-title":"J Cardiol"},{"key":"2022102708475990500_ehab276-B5","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"2022102708475990500_ehab276-B6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacl.2020.07.003","article-title":"Viewing atherosclerosis through a crystal lens: how the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability","volume":"14","author":"Nidorf","year":"2020","journal-title":"J Clin Lipidol"},{"key":"2022102708475990500_ehab276-B7","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"key":"2022102708475990500_ehab276-B8","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102708475990500_ehab276-B9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1194\/jlr.S091280","article-title":"Inflammasomes, neutrophil extracellular traps, and cholesterol","volume":"60","author":"Tall","year":"2019","journal-title":"J Lipid Res"},{"key":"2022102708475990500_ehab276-B10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/M18-1167","article-title":"Relationship of interleukin-1\u03b2 blockade with incident gout and serum uric acid levels: exploratory analysis of a randomized controlled trial","volume":"169","author":"Solomon","year":"2018","journal-title":"Ann Intern Med"},{"key":"2022102708475990500_ehab276-B11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinthera.2018.11.016","article-title":"Why colchicine should be considered for secondary prevention of atherosclerosis: an overview","volume":"41","author":"Nidorf","year":"2019","journal-title":"Clin Ther"},{"key":"2022102708475990500_ehab276-B12","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","article-title":"Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease: a LoDoCo2 proteomic substudy","volume":"142","author":"Opstal","year":"2020","journal-title":"Circulation"},{"key":"2022102708475990500_ehab276-B13","article-title":"A tale of two therapies lipid-lowering vs anti-inflammatory therapy\u2014a false dichotomy?","author":"Strandberg","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2022102708475990500_ehab276-B14","article-title":"Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns","author":"Galli","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2022102708475990500_ehab276-B15","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0140-6736(17)30752-3","article-title":"Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study","volume":"389","author":"Kaplan","year":"2017","journal-title":"Lancet"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/28\/2761\/46650751\/ehab276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/28\/2761\/46650751\/ehab276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T08:48:36Z","timestamp":1666860516000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/28\/2761\/6288115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":15,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2021,5,29]]},"published-print":{"date-parts":[[2021,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab276","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,21]]},"published":{"date-parts":[[2021,5,29]]}}}